TY - JOUR
T1 - Mechanical thrombectomy decision making and prognostication
T2 - Stroke treatment Assessments prior to Thrombectomy In Neurointervention (SATIN) study
AU - SATIN Research Group
AU - SATIN Research Group
AU - Fargen, Kyle M.
AU - Kittel, Carol
AU - Curry, Brian P.
AU - Hile, Connor W.
AU - Wolfe, Stacey Q.
AU - Brown, Patrick
AU - Mokin, Maxim
AU - Rai, Ansaar T.
AU - Chen, Michael
AU - Starke, Robert M.
AU - Albuquerque, Felipe C.
AU - Ansari, Sameer A.
AU - Kan, Peter
AU - Spiotta, Alejandro M.
AU - Dabus, Guilherme
AU - Leslie-Mazwi, Thabele M.
AU - Hirsch, Joshua A.
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2023/12/21
Y1 - 2023/12/21
N2 - BACKGROUND: Mechanical thrombectomy (MT) is the standard-of-care treatment for stroke patients with emergent large vessel occlusions. Despite this, little is known about physician decision making regarding MT and prognostic accuracy. METHODS: A prospective multicenter cohort study of patients undergoing MT was performed at 11 comprehensive stroke centers. The attending neurointerventionalist completed a preprocedure survey prior to arterial access and identified key decision factors and the most likely radiographic and clinical outcome at 90 days. Post hoc review was subsequently performed to document hospital course and outcome. RESULTS: 299 patients were enrolled. Good clinical outcome (modified Rankin Scale (mRS) score of 0-2) was obtained in 38% of patients. The most frequently identified factors influencing the decision to proceed with thrombectomy were site of occlusion (81%), National Institutes of Health Stroke Scale score (74%), and perfusion imaging mismatch (43%). Premorbid mRS score determination in the hyperacute setting accurately matched retrospectively collected data from the hospital admission in only 140 patients (46.8%). Physicians correctly predicted the patient's 90 day mRS tertile (0-2, 3-4, or 5-6) and final modified Thrombolysis in Ischemic Cerebral Infarction score preprocedure in only 44.2% and 44.3% of patients, respectively. Clinicians tended to overestimate the influence of occlusion site and perfusion imaging on outcomes, while underestimating the importance of pre-morbid mRS. CONCLUSIONS: This is the first prospective study to evaluate neurointerventionalists' ability to accurately predict clinical outcome after MT. Overall, neurointerventionalists performed poorly in prognosticating patient 90 day outcomes, raising ethical questions regarding whether MT should be withheld in patients with emergent large vessel occlusions thought to have a poor prognosis.
AB - BACKGROUND: Mechanical thrombectomy (MT) is the standard-of-care treatment for stroke patients with emergent large vessel occlusions. Despite this, little is known about physician decision making regarding MT and prognostic accuracy. METHODS: A prospective multicenter cohort study of patients undergoing MT was performed at 11 comprehensive stroke centers. The attending neurointerventionalist completed a preprocedure survey prior to arterial access and identified key decision factors and the most likely radiographic and clinical outcome at 90 days. Post hoc review was subsequently performed to document hospital course and outcome. RESULTS: 299 patients were enrolled. Good clinical outcome (modified Rankin Scale (mRS) score of 0-2) was obtained in 38% of patients. The most frequently identified factors influencing the decision to proceed with thrombectomy were site of occlusion (81%), National Institutes of Health Stroke Scale score (74%), and perfusion imaging mismatch (43%). Premorbid mRS score determination in the hyperacute setting accurately matched retrospectively collected data from the hospital admission in only 140 patients (46.8%). Physicians correctly predicted the patient's 90 day mRS tertile (0-2, 3-4, or 5-6) and final modified Thrombolysis in Ischemic Cerebral Infarction score preprocedure in only 44.2% and 44.3% of patients, respectively. Clinicians tended to overestimate the influence of occlusion site and perfusion imaging on outcomes, while underestimating the importance of pre-morbid mRS. CONCLUSIONS: This is the first prospective study to evaluate neurointerventionalists' ability to accurately predict clinical outcome after MT. Overall, neurointerventionalists performed poorly in prognosticating patient 90 day outcomes, raising ethical questions regarding whether MT should be withheld in patients with emergent large vessel occlusions thought to have a poor prognosis.
KW - CT perfusion
KW - Intervention
KW - Stroke
KW - Thrombectomy
UR - http://www.scopus.com/inward/record.url?scp=85151582355&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85151582355&partnerID=8YFLogxK
U2 - 10.1136/jnis-2022-019741
DO - 10.1136/jnis-2022-019741
M3 - Article
C2 - 36609542
AN - SCOPUS:85151582355
SN - 1759-8478
VL - 15
SP - e381-e387
JO - Journal of neurointerventional surgery
JF - Journal of neurointerventional surgery
IS - e3
ER -